Concord Biotech Financials Statements
Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios
Total Qtr Revenue cr | 287.74 | ||||
| Other Income Qtr Cr | 9.98 | ||||
| Operating Revenues Qtr | 277.77 | ||||
Loading chart... | |||||
Operating Expenses Qtr | 178.79 | ||||
Operating Profit Qtr | 98.98 | ||||
EBITDA Qtr Cr | 105.68 | ||||
Depreciation Qtr | 18.75 | ||||
Net Profit Qtr | 64.48 | ||||
Basic EPS Qtr | 6.08 | ||||